ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,226Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 307

$400K Total Retail Price of All Prescriptions

Rank: 32 out of 307

459 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,505 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LISINOPRIL 501 418 1 3
FUROSEMIDE 377 319 2 6
LEVOTHYROXINE SODIUM 312 261 3 1
SIMVASTATIN 280 247 4 2
HYDROCODONE-ACETAMINOPHEN 278 236 S3 5 4
METFORMIN HCL 264 215 6 8
POTASSIUM CHLORIDE 244 210 7 10
CITALOPRAM HBR 232 190 8 14
AMLODIPINE BESYLATE 223 185 9 7
OMEPRAZOLE 193 158 10 5
LOSARTAN POTASSIUM 192 180 11 16
ATENOLOL 170 135 12 17
WARFARIN SODIUM 163 128 13 11
METOPROLOL SUCCINATE 160 147 14 13
GABAPENTIN 127 90 15 15
SERTRALINE HCL 126 107 16 22
HYDROCHLOROTHIAZIDE 123 103 17 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 99 18 23
ATORVASTATIN CALCIUM 104 83 19 18
ZOLPIDEM TARTRATE 96 82 20 19
ALLOPURINOL 89 58 21 27
CARVEDILOL 81 78 22 24
ALENDRONATE SODIUM 80 72 23 20
METOPROLOL TARTRATE 80 43 23 12
GEMFIBROZIL 74 62 25 69
AZITHROMYCIN 74 60 25 55
PRAVASTATIN SODIUM 73 51 27 26
DONEPEZIL HCL 72 72 28 34
DOXAZOSIN MESYLATE 71 71 29 61
FENTANYL 70 54 S2 30 35
ADVAIR DISKUS 68 55 31 28
TRIAMTERENE-HCTZ 68 68 31 42
PREDNISONE 68 64 31 37
PROAIR HFA 67 38 34 53
SPIRIVA 64 51 35 48
OXYBUTYNIN CHLORIDE ER 61 50 36 110
PHENYTOIN SODIUM EXTENDED 60 13 37 101
NEXIUM 60 47 37 38
TAMSULOSIN HCL 59 50 39 21
DIGOXIN 58 57 40 36
DIOVAN 57 48 41 58
OXYCODONE-ACETAMINOPHEN 56 41 S2 42 63
CYMBALTA 56 30 42 30
CRESTOR 56 40 42 39
GLIMEPIRIDE 52 34 45 60
NOVOLOG 52 48 45 109
TRIAMCINOLONE ACETONIDE 52 44 45 129
MELOXICAM 52 36 45 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.